• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危健康状况与技术:诊断邀请及知晓的“馈赠”。

The at-risk health status and technology: a diagnostic invitation and the 'gift' of knowing.

作者信息

Kenen R H

机构信息

Department of Sociology and Anthropology, Trenton State College, NJ 08650-4700, USA.

出版信息

Soc Sci Med. 1996 Jun;42(11):1545-53. doi: 10.1016/0277-9536(95)00248-0.

DOI:10.1016/0277-9536(95)00248-0
PMID:8771637
Abstract

In the past two decades, the medical model has extended its jurisdiction to cover a new medical entity-the at-risk health status-which is frequently accompanied by what I call a diagnostic invitation and the 'gift' of knowing. In cases, however, where the diagnosis may only reaffirm the risk but can provide no cure, the value of the 'gift' of knowing is questioned. The at-risk health status also can: (1) develop a symbiotic relationship with diagnostic technology, (2) become an organizing principle in individual and social behavior and (3) provide new tasks for clinical medicine. The perceived cost effectiveness of preventive measures, combined with the desire to use high-technology medicine, to achieve newly expanded definitions of health make it likely that the concept of the at-risk health status will be integrated into whatever health care plan is finally enacted for the United States. In light of the possible negative, as well as positive, effects of at-risk health labelling, American society needs to establish standards for the diagnostic invitation as a gift of knowing especially when the line between prevention and overuse is not always clear.

摘要

在过去二十年中,医学模式已将其管辖范围扩大,涵盖了一个新的医学实体——健康风险状态,这种状态常常伴随着我所说的诊断诱因以及知晓的“馈赠”。然而,在某些情况下,诊断可能只会再次确认风险,却无法提供治愈方法,这时知晓的“馈赠”的价值就受到了质疑。健康风险状态还可能:(1)与诊断技术形成共生关系,(2)成为个人和社会行为的组织原则,(3)为临床医学带来新任务。预防措施的成本效益被认为很高,再加上人们希望使用高科技医学来实现对健康的新扩展定义,这使得健康风险状态的概念很可能会被纳入最终为美国制定的任何医疗保健计划中。鉴于健康风险标签可能产生的负面和正面影响,美国社会需要为作为知晓馈赠的诊断诱因制定标准,尤其是在预防和过度使用之间的界限并不总是清晰的时候。

相似文献

1
The at-risk health status and technology: a diagnostic invitation and the 'gift' of knowing.高危健康状况与技术:诊断邀请及知晓的“馈赠”。
Soc Sci Med. 1996 Jun;42(11):1545-53. doi: 10.1016/0277-9536(95)00248-0.
2
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
3
[An invasion of non-invasive diagnostic tests].[无创诊断测试的侵袭性]
Med Sci (Paris). 2014 Jan;30(1):107-8. doi: 10.1051/medsci/20143001022. Epub 2014 Jan 24.
4
Genetic testing and health insurance practices: an industry perspective.基因检测与健康保险业务:行业视角
Genet Test. 1998;2(1):9-12. doi: 10.1089/gte.1998.2.9.
5
Psychosocial correlates of pregnant women's attitudes toward prenatal maternal serum screening and invasive diagnostic testing: beyond traditional risk status.孕妇对产前母体血清筛查和侵入性诊断检测态度的社会心理相关因素:超越传统风险状况
Genet Test. 2006 Summer;10(2):131-8. doi: 10.1089/gte.2006.10.131.
6
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
7
[Are schizophrenic patients being told their diagnosis today in France?].[如今在法国,精神分裂症患者会被告知他们的诊断结果吗?]
Encephale. 2017 Apr;43(2):160-169. doi: 10.1016/j.encep.2016.01.011. Epub 2016 Jun 29.
8
Reassuring patients about normal test results.向患者保证检查结果正常。
BMJ. 2007 Feb 17;334(7589):325. doi: 10.1136/bmj.39121.361910.80.
9
Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.获取诊断性胎儿标本或组织的产前诊断程序和技术:母婴风险与益处
J Obstet Gynaecol Can. 2015 Jul;37(7):656-668. doi: 10.1016/S1701-2163(15)30205-X.
10
Educating trainees about appropriate and cost-conscious diagnostic testing.培训学员如何进行合理且注重成本效益的诊断检测。
Acad Med. 2011 Nov;86(11):1352. doi: 10.1097/ACM.0b013e3182308db7.

引用本文的文献

1
Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: Beyond the diagnosis.父母选择进行三体外显子组测序的动机及适应情况:超越诊断。
Prenat Diagn. 2022 May;42(6):775-782. doi: 10.1002/pd.6112. Epub 2022 Feb 16.
2
An Analysis of Public-Private Partnerships and Sustainable Health Care Provision in the Kingdom of Saudi Arabia.沙特阿拉伯王国公私合作伙伴关系与可持续医疗保健提供情况分析
Health Serv Insights. 2019 Jul 4;12:1178632919859008. doi: 10.1177/1178632919859008. eCollection 2019.
3
Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.
理解乳腺癌预防决策:感知风险、感知控制和社会背景的交集:NRG 肿瘤学/NSABP DMP-1。
Med Decis Making. 2019 Apr;39(3):217-227. doi: 10.1177/0272989X19827258. Epub 2019 Feb 25.
4
Patients-in-waiting or chronically healthy individuals? People with elevated cholesterol talk about risk.等待治疗的患者或长期健康的个体?高胆固醇人群谈论风险。
Sociol Health Illn. 2019 Jun;41(5):867-881. doi: 10.1111/1467-9566.12866. Epub 2019 Jan 22.
5
Healthcare provider and patient perspectives on diagnostic imaging investigations.医疗服务提供者和患者对诊断性影像学检查的看法。
Afr J Prim Health Care Fam Med. 2015 May 20;7(1):801. doi: 10.4102/phcfm.v7i1.801.
6
Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.管理遗传性癌症风险的挑战:对携带BRCA1/BRCA2突变的未受影响女性的长期定性研究
Genet Med. 2015 Sep;17(9):726-32. doi: 10.1038/gim.2014.183. Epub 2014 Dec 11.
7
Genetic counseling for the next 25 years: Models for the future.
J Genet Couns. 1995 Jun;4(2):115-24. doi: 10.1007/BF01408634.
8
Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research.弱势群体中个体乳腺癌风险评估:整合实证生物伦理学与健康差异研究
J Health Care Poor Underserved. 2012 Nov;23(4 Suppl):34-46. doi: 10.1353/hpu.2012.0178.
9
Women's experiences receiving abnormal prenatal chromosomal microarray testing results.女性接受异常产前染色体微阵列检测结果的体验。
Genet Med. 2013 Feb;15(2):139-45. doi: 10.1038/gim.2012.113. Epub 2012 Sep 6.
10
Rethinking scientific responsibility.重新思考科学责任。
J Med Ethics. 2011 May;37(5):299-302. doi: 10.1136/jme.2010.038828. Epub 2011 Jan 25.